Conventional mental health therapies have offered little help. But a growing number of professional athletes are finding the path back to a better life with a more unconventional therapy—psychedelics. These five athletes are leading the way in psychedelic therapy.
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
New study brings hope to cancer patients struggling with depressive symptoms. Conflicts in Kentucky commission developing plan to fund research on the benefits of ibogaine to treat opioid addiction. Ayahuasca played a key role in finding Colombian children stranded in the Amazonian jungle.
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.
Researchers at Imperial’s Centre for Psychedelic Research will investigate psilocybin-assisted therapy for gambling addiction, aiming to improve their understanding of brain function in gambling disorder.
The bronze age psychedelics: hair strands unveil Europe’s earliest recorded hallucinogenic drug use 3000 years ago.
Psychedelic decriminalization has long been the goal of many activists, but it is a long way from true legalization. What’s the difference?
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
